Anna Maria Frustaci

1.5k citations
63 papers · 515 indexed · h-index 15

Anna Maria Frustaci

57 papers receiving 504 citations

Peers

Anna Maria Frustaci
Comparison fields: 5 of 54
  • Genetics 287
  • Hematology 181
  • Pathology and Forensic Medicine 133
  • Oncology 111
  • Infectious Diseases 64
Replace Silvana Capalbo with:
Silvana Capalbo Italy
Małgorzata Całbecka Poland
Sumie Tabata Japan
Matthew T. Howard United States
Ana Sureda Spain
Marguerite Vignon France
Hiroshi Ureshino Japan
Maurizio Longinotti Italy
Christoph Scheid Germany
Keiki Kawakami Japan
Anna Maria Frustaci relative to Silvana Capalbo Italy Silvana Capalbo's profile →
Citations per field
00.5×8.7×
Silvana Capalbo · 1×
Citations per year

Countries citing papers authored by Anna Maria Frustaci

Since Specialization
Citations

This map shows the geographic impact of Anna Maria Frustaci's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Maria Frustaci with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Maria Frustaci more than expected).

Fields of papers citing papers by Anna Maria Frustaci

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Maria Frustaci. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Maria Frustaci. The network helps show where Anna Maria Frustaci may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Anna Maria Frustaci, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Anna Maria Frustaci Line = papers co-authored together Anna Maria Frustaci links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20250
2 20242
3 20240
4 202414
5 20241
6 20241
7 20247
8 20234
9 20231
10 20232
11 202331
12 20211
13 20211
14 20157
15 201318
16 201035
17 20097
18 20071
19 200626
20 20061

About Anna Maria Frustaci

Anna Maria Frustaci is a scholar working on Genetics, Hematology and Pathology and Forensic Medicine, having authored 63 papers that have together received 515 indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (49 papers), Lymphoma Diagnosis and Treatment (27 papers), Chronic Myeloid Leukemia Treatments (15 papers), Immunodeficiency and Autoimmune Disorders (14 papers), Acute Lymphoblastic Leukemia research (7 papers), Advanced Breast Cancer Therapies (6 papers), Acute Myeloid Leukemia Research (6 papers) and Eosinophilic Disorders and Syndromes (4 papers). The work is most often cited by research in Genetics (287 citations), Hematology (181 citations) and Pathology and Forensic Medicine (133 citations). Anna Maria Frustaci has collaborated with scholars based in Italy, United States and Australia. Frequent co-authors include Alessandra Tedeschi, Massimo Breccia, Roberto Cairoli, Marco Montillo, Marina Deodato, Giuliana Alimena, Roberto Latagliata, Laura Cannella, Caterina Stefanizzi and Ida Carmosino. Their work appears in journals such as Journal of Clinical Oncology, Blood and Neurology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026